The Pharmacy Times® Pain Management resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, among other items that pharmacists will find valuable.
What can we help you find?
A cohesive overview of the classes of agents used to treat patients with opioid-induced constipation.
The panel reflects on the role of a pharmacist in the identification and management of opioid-induced constipation.
A Multimodal Analgesic Approach Can Improve the Quality of Analgesia and Reduce Adverse Effects.
Letter to the Editor: Re: the Health & Wellness article “What Are the Options for Treating Pain?” in the September issue of Pharmacy Times®:
"Opioids are associated with significant side effects in some patients, side effects that can frequently be managed by ancillary therapies."
The FDA has previously sent warning letters to other companies for illegally selling CBD products that had claimed to prevent, diagnose, mitigate, treat, or cure serious diseases, such as cancer.
Shared insight on the open dialogues that should take place between patients with opioid-induced constipation and care providers.
These health care professionals should receive education on how to prevent opioid misuse.
Key opinion leaders provide their perspectives on the goals of therapy and prophylactic management of opioid-induced constipation.
A comprehensive review of opioid-induced constipation diagnosis strategies and foundational treatment guidelines.
A panel of experts considers the disease pathology of opioid-induced constipation and the burden it has on patients.
As approved delegates, techs can assist pharmacists by reviewing prescription drug monitoring programs.
Why is this woman in opioid withdrawal despite high dose methadone administration?